The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

A new report from the World Organisation for Animal Health (WOAH) reveals that 16 more poultry flocks were affected by highly ...

Influenza A (H1N1)pdm09 Virus Therapeutics and Challenges Shailendra K Saxena; Rosaiah Kotikalapudi; Sneham Tiwari; Charuvaka Muvva Disclosures Future Virology. 2012;7 (10):947-950.

Led by the International Fact-Checking Network (IFCN) at the Poynter Institute, the #CoronaVirusFacts / #DatosCoronaVirus Alliance unites more than 100 fact-checkers around the world in publishing ...

This was performed to allow for greater mortality, and thus potentially greater vaccine impact, in influenza seasons dominated by influenza A/H3N2 viruses than those dominated by influenza A/H1N1 or B ...

Influenza A virus (IAV) infection triggers derepression of host transposable elements (TEs), which have the potential to form double-stranded (ds)RNAs and could enhance innate antiviral immunity.

Mortality and economic contraction during the 1918-1920 Great Influenza Pandemic provide plausible upper bounds for outcomes under the coronavirus (COVID-19). Data for 48 countries imply flu-related ...

Influenza A virus infection causes a contagious respiratory illness that poses a threat to human health. However, there are limited anti-influenza A therapeutics available, which is further compounded ...

The nucleoprotein (NP) of influenza A virus (IAV) required for IAV replication is a promising target for new antivirals. We previously identified by in silico screening naproxen being a dual inhibitor ...